42 results
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
not use financial instruments for trading purposes and have not issued or acquired derivative financial instruments for hedging purposes. The following
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
instruments for hedging purposes. The following table presents the carrying amounts of our financial instruments at March 31, 2023 and December 31, 2022
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
15 Dec 22
Notice of Special Meeting of Shareholders
4:03pm
"functional currency" is not the U.S. dollar; (ix) persons holding Common Shares as a position in a hedging transaction, "straddle," "conversion
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
for trading purposes and have not issued or acquired derivative financial instruments for hedging purposes. The following table presents the carrying
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
10 Aug 22
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
12:00am
derivative financial instruments for hedging purposes. The following table presents the carrying amounts of our financial instruments at June 30
6-K
EX-99.2
dingm xnxyjd
10 May 22
Liminal BioSciences Reports First Quarter 2022 Financial Results and Business Highlights
4:55pm
6-K
EX-99.2
zga3w7
16 Nov 21
Liminal BioSciences Reports Third Quarter 2021 Financial Results
12:00am
6-K
EX-99.2
i2hwaj0y
16 Aug 21
Liminal BioSciences Reports Second Quarter 2021 Financial Results
5:08pm
6-K
EX-99.2
txizukwx
17 May 21
Liminal BioSciences Reports First Quarter 2021 Financial Results
5:11pm
424B3
v1s 4cqxx955l7raanz
11 Dec 20
Prospectus supplement
12:00am
424B3
67foazd2bm
10 Dec 20
Prospectus supplement
9:53pm
POS AM
64vdfndyr
2 Dec 20
Prospectus update (post-effective amendment)
12:00am
F-3
t89 5pgw6xzb
2 Dec 20
Shelf registration (foreign)
12:00am
424B3
br6r9z4
12 Nov 20
Prospectus supplement
5:21pm
6-K
EX-99.2
lq0m p7bw
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
6-K
EX-99.2
xbo7ubltw4fl22b16
2 Nov 20
Securities Purchase Agreement
8:45am
424B3
uu38501xcf0azlzy43x
30 Sep 20
Prospectus supplement
5:14pm
F-1/A
yoskzaele5bt7s
14 Sep 20
Registration statement (foreign) (amended)
4:56pm